Up 38.5% in One Year, Exosens Stock Advances 2% During Trading Session
The Bordeaux-based optronic company reclaims its position in the upper ranks of the SBF 120 while the index declines. The stock thus emerges from the pullback zone that had characterized the end of last week.
A Rebound That Brings the Price Back Above the 20-Day, 50-Day and 200-Day Moving Averages
Exosens stock gains 2.03% to €60.40 in early afternoon trading, moving against the grain of a SBF 120 that yields 0.5%. This movement places it at the 12th position on the index for the session. The stock moves back above its three moving averages: the 20-day MA at €58.69 (spread of 2.91%), the 50-day MA at €60.00 (spread of 0.67%) and the 200-day MA at €59.73.
The price is only 0.67% from the 50-day MA and 1.12% from the 200-day MA, meaning that these two thresholds remain close to the current price. The RSI at 48 is neutral. Over seven days, the stock remains down 3.05%, but it shows +9.42% over one month.
A Series of Analyst Opinions and Target Price Increases That Preceded the Rebound
The group had raised its annual targets on September 17, with revenue targeted up to €570 million and adjusted EBITDA growth of approximately 25% in 2026. The stock surged nearly 10% that day. Bernstein subsequently raised its price target to €74 on September 23, but the stock retreated 3.5% the following day, then lost ground on September 25.
Support is found at €54.15 and resistance at €63.40, which is 5% above the current price. Results for the first nine months are expected on October 27.
